DEA schedule
Is Jakafi a controlled substance?
Jakafi contains ruxolitinib. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Jakafi (ruxolitinib) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ruxolitinib is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Jakafi?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 5 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | ruxolitinib is not on the list |
Jakafi NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 50881-010 | JAKAFI | tablet | 10 mg/1 | Incyte Corporation | None |
| 50881-015 | JAKAFI | tablet | 15 mg/1 | Incyte Corporation | None |
| 50881-020 | JAKAFI | tablet | 20 mg/1 | Incyte Corporation | None |
| 50881-025 | JAKAFI | tablet | 25 mg/1 | Incyte Corporation | None |
| 50881-005 | JAKAFI | tablet | 5 mg/1 | Incyte Corporation | None |
Questions
Is Jakafi a controlled substance?
No. Jakafi (ruxolitinib) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and ruxolitinib is not on the DEA controlled substances list.
Is Jakafi a narcotic?
No. Jakafi (ruxolitinib) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Janus Kinase Inhibitor and Kinase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Jakafi
- What is Jakafi used for?FDA label uses
- Generic for JakafiFDA Orange Book
- Generic for OpzeluraFDA Orange Book
- Generic for Jakafi XRFDA Orange Book
- Janus Kinase Inhibitors listFDA drug class
- Kinase Inhibitors listFDA drug class
- Jakafi Medicare Part D coverageBy plan and state
- NDC 50881-005Jakafi NDC record
- NDC 50881-010Jakafi NDC record
- NDC 50881-015Jakafi NDC record